Transitive dependency

CleanSlate Centers, National Accredited Addiction Treatment Group, Announces State-level Treatment Licensing Requirements Achieved by Arlington, Texas Location

Retrieved on:

星期三, 二月 16, 2022

Patient, Transitive dependency, Accreditation, Texas Health and Human Services Commission, Operation Cleanslate, Opioid epidemic, Mental health, Conditional sentence, Commission on Accreditation of Rehabilitation Facilities, Commission, University of Texas Health Science Center at Houston, Multimedia, CARF, Industry, Medicine, Hospital

The new license, effective December 13, 2021, will allow CleanSlate Centers (CleanSlate) to begin behavioral health services for patients within the state.

Key Points:

The new license, effective December 13, 2021, will allow CleanSlate Centers (CleanSlate) to begin behavioral health services for patients within the state.
CleanSlate strives tofulfill and achieve the highest standards, licenses and certifications of care across the country.
CleanSlate has also met thousands of clinical and operational standards in order to be licensed and accredited as an office-based opioid treatment (OBOT) provider, fulfilling both national and state-specific requirements.
CleanSlate is a national medical group that provides physician-led, office-based treatment for individuals suffering from mental and behavioral health diagnoses, as well as opioid and alcohol use disorders.

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Alcohol Use Disorder in Europe

Retrieved on:

星期四, 一月 27, 2022

Mothers (Tokyo Stock Exchange), Intention, Depression, NASDAQ, Nasdaq, Addiction, Transitive dependency, Tokyo Stock Exchange, MPH, MD, Code, GLOBE, Patent, Pharmaceutical industry, Doctor of Philosophy

Once issued, the patent maturing from this allowed patent application is expected to expire no earlier thanMay 2037.

Key Points:

Once issued, the patent maturing from this allowed patent application is expected to expire no earlier thanMay 2037.
Kazuko Matsuda, MD, PhD, MPH, Chief Medical Officer ofMediciNova, Inc., commented, "We are very pleased to receive notice that this new patent will be granted.
A third NIH-funded clinical trial of MN-166 in alcohol use disorder is currently ongoing in collaboration with UCLA.
Alcohol use disorder (AUD) is a prevalent and disabling psychiatric disorder with limited treatment options.

LifeWorks acquires Breaking Free, a leading provider of digital substance use disorder treatment

Retrieved on:

星期一, 一月 24, 2022

LifeWorks, a leading provider of comprehensive mental health, digital and in-person total wellbeing solutions, announced the acquisition of Breaking Free, a provider of evidence-based behavioural health SaaS solutions for substance use intervention.

Key Points:

LifeWorks, a leading provider of comprehensive mental health, digital and in-person total wellbeing solutions, announced the acquisition of Breaking Free, a provider of evidence-based behavioural health SaaS solutions for substance use intervention.
Todays acquisition supports the strategic direction to grow the capability offered by the LifeWorks platform and enhances the mental health and total wellbeing offerings to care for individuals that need support for both substance use and other mental health concerns.
This acquisition will accelerate LifeWorks growth, over time, by adding substance use solutions to its platform and making these available to the more than 25,000 client organisations that already rely on LifeWorks mental health and wellbeing services.
The Canadian Mental Health Association estimates that five per cent of the worlds population has used an illicit substance.

LifeWorks acquires Breaking Free, a leading provider of digital substance use disorder treatment

Retrieved on:

星期一, 一月 24, 2022

LifeWorks, a leading provider of comprehensive mental health, digital and in-person total wellbeing solutions, announced the acquisition of Breaking Free, a provider of evidence-based behavioral health SaaS solutions for substance use intervention.

Key Points:

LifeWorks, a leading provider of comprehensive mental health, digital and in-person total wellbeing solutions, announced the acquisition of Breaking Free, a provider of evidence-based behavioral health SaaS solutions for substance use intervention.
Todays acquisition supports the strategic direction to grow the capability offered by the LifeWorks platform and enhances the mental health and total wellbeing offerings to care for individuals that need support for both substance use and other mental health concerns.
This acquisition will accelerate LifeWorks growth, over time, by adding substance use solutions to its platform and making these available to the more than 25,000 client organizations that already rely on LifeWorks mental health and wellbeing services.
The Canadian Mental Health Association estimates that five percent of the worlds population has used an illicit substance.

Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and 'Psychedelic Concierge' Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health

Retrieved on:

星期四, 十月 14, 2021

As a world-leading depression researcher, Dr. Roger McIntyre has been named one of the world's most influential scientific minds by Clarivate for seven consecutive years.

Key Points:

As a world-leading depression researcher, Dr. Roger McIntyre has been named one of the world's most influential scientific minds by Clarivate for seven consecutive years.
Lamar Odom is a two-time National Basketball Association champion, Olympic gold medalist, New York Times bestselling author, and mental health advocate.
Zappy Zapolin is the co-founder and executive chairman of KetaMD , a developing telemedicine platform that provides at-home medical ketamine treatments.
"Dr. McIntyre and I are very mission-aligned on the untapped benefits of psychedelics in the treatment of many mental health conditions," says Zappy Zapolin, co-founder of KetaMD and director of Reborn.

Compass Health Unveils “Andy’s Place” as Official Name of New Permanent Supportive Housing Building on Broadway Campus

Retrieved on:

星期三, 九月 8, 2021

Philanthropy, Public Policy, Government, Mental Health, State, Local, Health, Foundation, General Health

Today, Compass Health unveiled Andys Place as the official name of the organizations new permanent supportive housing building completed during Phase I of the three-phase Broadway Campus Redevelopment project.

Key Points:

Today, Compass Health unveiled Andys Place as the official name of the organizations new permanent supportive housing building completed during Phase I of the three-phase Broadway Campus Redevelopment project.
We are incredibly grateful for the Martyn Family Foundation for this generous gift, which allows Compass Health to provide hope and recovery for individuals who share Andys challenges, said Tom Sebastian, Compass Health president and CEO.
Completed in 2021, Andys Place includes 82 new units of housing, coupled with facilities for integrated treatment and supportive services for people with chronic behavioral health challenges.
When complete, Phase II will help make the Broadway Campus a robust resource as a sophisticated facility for people with intensive behavioral health needs, right next door to the permanent supportive housing that Andys Place provides.